Key result
Rivaroxaban successfully manages chronic DIC in a TAAA patient with no complications over 9 months.
Why the study?
In geriatric patients, aortic aneurysm or chronic aortic dissection must be considered as potential causes of life-threatening chronic disseminated intravascular coagulation.
Case Report (n=1)
No
Rivaroxaban may be an effective conservative treatment for chronic DIC secondary to a large thoracoabdominal aortic aneurysm with persistent type B dissection in frail patients unsuitable for surgery.
Rivaroxaban may support conservative management of chronic DIC in frail inoperable patients; leaves open need for prospective confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fialová et al. (2022) conducted a case report in Chronic disseminated intravascular coagulation (DIC) caused by chronic dissection and aneurysm of thoracoabdominal aorta (n=1). Rivaroxaban was evaluated on Bleeding or thrombotic complications. Conservative treatment with rivaroxaban successfully managed chronic disseminated intravascular coagulation in a patient with a thoracoabdominal aortic aneurysm and chronic dissection, with no bleeding or thrombotic complications over 9 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: